|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| A61K 31/5377 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3177619 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15744596.6 |
| Date of filing the European patent application | 2015-08-03 | |
| (97) | Date of publication of the European application | 2017-06-14 |
| (45) | Date of publication and mention of the grant of the patent | 2018-04-25 |
| (46) | Date of publication of the claims translation | 2018-08-10 |
| (86) | Number | PCT/EP2015/067804 |
| Date | 2015-08-03 |
| (87) | Number | WO 2016/020320 |
| Date | 2016-02-11 |
| (30) | Number | Date | Country code |
| 14179692 | 2014-08-04 | EP | |
| 15159342 | 2015-03-17 | EP |
| (72) |
WORTMANN, Lars, DE
LÜCKING, Ulrich, DE
LEFRANC, Julien, DE
BRIEM, Hans, DE
KOPPITZ, Marcus, DE
EIS, Knut, DE
VON NUSSBAUM, Franz, DE
BADER, Benjamin, DE
WENGNER, Antje Margret, DE
SIEMEISTER, Gerhard, DE
BONE, Wilhelm, DE
LIENAU, Philip, DE
GRUDZINSKA-GOEBEL, Joanna, DE
MOOSMAYER, Dieter, DE
EBERSPÄCHER, Uwe, DE
SCHICK, Hans, DE
|
| (73) |
Bayer Pharma Aktiengesellschaft,
Müllerstrasse 178, 13353 Berlin,
DE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | 2-(Morfolin-4-il)-1,7-naftiridinai |
| 2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES |
| Payment date | Validity (years) | Amount | |
| 2023-07-19 | 9 | 208.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-08-03 |